JAN 15, 2019 5:24 PM PST

Decipher the Clues with CRISPR

WRITTEN BY: Nicholas Breehl

Scientists have created the first retroviral CRISPR-Cas9 gene editing library to explore the regulation of mouse T cells, which are critical cells in the immune system. Researchers from the Welcome Sanger Institute and their collaborators have mapped the most important genes for controlling T helper cells and identified several new regulatory genes. These could help scientists looking to develop new treatments to activate the immune system against infection or to attack tumor cells.

Published today (Jan. 10) in Cell, the study deciphers the complex control mechanism, with many different genes involved in both activation and development of T helper cells. Understanding what regulates T cell development could also help find new drugs against auto-immune diseases such as allergies or rheumatoid arthritis, caused by an over-active immune system.

 

The immune system protects the body against infection and tumors, and T helper type 2 cells (Th2) are a vital component of this, releasing specific chemicals to tell the body to kill invaders. T helper cells are switched on when an invader is detected. They then need to develop down precisely the right pathway to best help remove that specific infection, a process known as differentiation. However, it is unclear correctly what signals activate these cells or tell them how to develop and which chemical signals to release.

To investigate this, the researchers created a new genome-wide CRISPR library of 88,000 guides that enabled them to switch off each of the 20,000 genes from mouse Th2 cells. After mimicking an infection in cultured Th2 cells, they studied how switching off every single gene in the genome affect the activation or differentiation. They found many different genes involved in regulating Th2 development and defined the gene regulatory network.

 

Dr. Johan Henriksson, a joint first author from the Wellcome Sanger Institute and the Karolinska Institute, Sweden, said: "This is the first ever unbiased genome-wide analysis of the activation and differentiation of T helper cells, helping us understand which signals are involved in immune system regulation. Our study shows that many different types of genes impact both the activation and differentiation of these immune cells, indicating how closely linked those two processes are."

 

It is vital that the activation and differentiation of the Th2 cells are well controlled. Ineffective Th2 cells leave an infection unchecked, whereas if they are too active, the body can attack itself in autoimmunity. The study identified several new regulatory genes and discovered that the transcription factor PPARG is particularly crucial for regulating Th2 cells.

 

Dr. Xi Chen shared, "In the past, immunologists have been investigating Th2 mostly one gene at a time. In this study, we developed a new retroviral CRISPR library, which has enabled us to efficiently knock-out each gene in mouse T helper cells for the first time. We combined the CRISPR screen with other genomic technologies to gain a systematic overview of these immune cells. This has not only allowed us to identify genes involved in the regulation of Th2 cells but could also be used to study other mouse immune cells and their regulation."

 

Dr. Sarah Teichmann, the senior author from the Wellcome Sanger Institute and the University of Cambridge, said: "This study will help drive forward our understanding of the immune system. We have created an atlas of the most important genes involved in the regulation of T helper cell immune response and highlighted particular genes for further study. This openly available resource will be handy for scientists studying the immune system, and could lead to finding new immune-activating therapeutics against tumors and infections, or for damping down the immune response to relieve allergies in the future."

Sources: Science Daily, Cell, YouTube

About the Author
You May Also Like
JUN 15, 2020
Drug Discovery & Development
FDA Approves HPV Vaccine to Prevent Throat Cancer
JUN 15, 2020
FDA Approves HPV Vaccine to Prevent Throat Cancer
For around a decade, research has suggested that Gardasil, an HPV vaccine, could prevent throat cancer, a condition that ...
JUN 15, 2020
Drug Discovery & Development
New Antibiotic 'Irresistin' Defeats All Resistant Bacteria
JUN 15, 2020
New Antibiotic 'Irresistin' Defeats All Resistant Bacteria
Researchers from Princeton University have identified a compound capable of killing both Gram-positive and Gram-negative ...
JUN 15, 2020
Immunology
Experimental MS Treatment Relies on "Retraining" the Immune System
JUN 15, 2020
Experimental MS Treatment Relies on "Retraining" the Immune System
When the immune system goes awry and fails to regulate itself, immune cells may attack the body’s own tissues. Sci ...
JUL 14, 2020
Immunology
Itsy Bitsy Nanobodies to Defeat the Big Bad Coronavirus
JUL 14, 2020
Itsy Bitsy Nanobodies to Defeat the Big Bad Coronavirus
Scientists are working on developing an arsenal of nano-sized weapons in the war against COVID-19. These molecules, call ...
JUL 15, 2020
Immunology
Immune Memory to Thwart Recurring Cancer
JUL 15, 2020
Immune Memory to Thwart Recurring Cancer
Preventing cancer from returning in the body is an integral part of any anti-cancer treatment plan. New discoveries from ...
AUG 17, 2020
Immunology
Nervous Protein Neuromedin B May Prevent Immune Reactivity
AUG 17, 2020
Nervous Protein Neuromedin B May Prevent Immune Reactivity
A protein produced by the nervous system seems to play a role in regulating the immune system. For people with inflammat ...
Loading Comments...